High Expression of Long Noncoding RNA PCNA-AS1 Promotes Non-Small-Cell Lung Cancer Cell Proliferation and Oncogenic Activity via Upregulating CCND1
Chuanyong Wu, Xiao‐ting Zhu, Lei Xia, Lin Wang, Wenjun Yu, Qiaomei Guo, Mingna Zhao, Jiatao Lou · Journal of Cancer · 2020
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2020
Abstract
Accumulating evidences showed that aberrantly expressed long noncoding RNAs (lncRNAs) have critical roles in many cancers.However, the expression and roles of a poorly studied lncRNA PCNA-AS1 in non-small-cell lung cancer (NSCLC) remain unknown.In this study, we investigated the expression, clinical significance, biological roles, and functional mechanism of PCNA-AS1 in NSCLC.Our results showed that PCNA-AS1 was upregulated in NSCLC tissues and cell lines, and correlated with TNM stages.Functional experiments showed that overexpression of PCNA-AS1 promoted NSCLC cell proliferation and cell cycle progression.Depletion of PCNA-AS1 inhibited NSCLC cell proliferation and cell cycle progression, and also inhibited NSCLC tumor growth in vivo.Mechanistically, we found that PCNA-AS1 upregulated CCND1 expression.The expression of PCNA-AS1 was positively correlated with that of CCND1 in NSCLC tissues.Moreover, depletion of CCND1 abrogated the oncogenic roles of PCNA-AS1 in NSCLC.In conclusion, highly expressed PCNA-AS1 promotes NSCLC cell proliferation and oncogenic activity via upregulating CCND1.Our results imply that PCNA-AS1 might serve as a therapeutic target for NSCLC.
Open the resolved locator · 10.7150/jca.39087
Metadata licence: OpenAlex metadata (CC0)